Fujian, China

Tianshu Shi

This inventor holds 1 USPTO granted patent. Top assignees: Xiamen University, Yang Sheng Tang Company Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tianshu Shi. Retrieved from https://idiyas.com/inventor/tianshu-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tianshu Shi: Innovator in Antiviral Treatments

Introduction

Tianshu Shi is a notable inventor based in Fujian, China. He has made significant contributions to the field of antiviral treatments, particularly in the fight against hepatitis B. His innovative approach has led to the development of a specific compound aimed at combating the HBV virus.

Latest Patents

Tianshu Shi holds a patent for the "Use of palovarotene in treatment against HBV virus." This patent relates to antiviral treatment methods for hepatitis B, specifically focusing on the application of a compound represented by a specific formula in the treatment against the HBV virus. He has 1 patent to his name, showcasing his dedication to advancing medical science.

Career Highlights

Throughout his career, Tianshu Shi has worked with reputable organizations, including Yang Sheng Tang Company Limited and Xiamen University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Tianshu Shi has collaborated with notable colleagues such as Tianying Zhang and Ningshao Xia. These partnerships have enriched his research and expanded the impact of his work in antiviral treatments.

Conclusion

Tianshu Shi's contributions to antiviral treatment, particularly against hepatitis B, highlight his role as an innovator in the medical field. His patent and collaborations reflect his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…